Assessment of Statin Treatment for Pulmonary Alveolar Proteinosis without Hypercholesterolemia: A 12-Month Prospective, Longitudinal, and Observational Study.

Shi, Shenyun; Gui, Xianhua; Ding, Jingjing; Yang, Shangwen; Xin, Xiaoyan; Xu, Kaifeng; Xiao, Yonglong

Shi, Shenyun; Gui, Xianhua; Ding, Jingjing; Yang, Shangwen; Xin, Xiaoyan; Xu, Kaifeng; Xiao, Yonglong.

Afiliação

Shi S; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008 Jiangsu, China.
Gui X; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008 Jiangsu, China.
Ding J; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008 Jiangsu, China.
Yang S; Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008 Jiangsu, China.
Xin X; Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008 Jiangsu, China.
Xu K; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Beijing, China.
Xiao Y; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008 Jiangsu, China.

Biomed Res Int ; 2022: 1589660, 2022.

Article em En | MEDLINE | ID: mdl-36330458

Assuntos

Inibidores de Hidroximetilglutaril-CoA Redutases; Hipercolesterolemia; Proteinose Alveolar Pulmonar; Humanos; Proteinose Alveolar Pulmonar/tratamento farmacológico; Proteinose Alveolar Pulmonar/metabolismo; Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico; Hipercolesterolemia/tratamento farmacológico; Hipercolesterolemia/metabolismo; Estudos Prospectivos; Atorvastatina/uso terapêutico; Fator Estimulador de Colônias de Granulócitos e Macrófagos; Macrófagos Alveolares/metabolismo; HDL-Colesterol/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteinose Alveolar Pulmonar / Inibidores de Hidroximetilglutaril-CoA Redutases / Hipercolesterolemia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google